NCT06726850 Clinical Study to Evaluate the Efficacy and Safety of GS1-144 Tablets in the Treatment of Moderate to Severe Vasomotor Symptoms in Chinese Postmenopausal Women. Status COMPLETED Phase PHASE2
NCT06726278 Significance of Misoprostol-induced Cervical Ripening Prior to Hysteroscopy Status COMPLETED Phase NA
NCT06725017 A Phase 2 Study to Evaluate the Efficacy and Safety of Live SK08 Powder in Adult Patients with Active Mild to Moderate Ulcerative Colitis Status NOT_YET_RECRUITING Phase PHASE2
NCT06724640 A Study to Assess the Safety, Tolerability, and Pharmacokinetics of VH4011499 Compared to Placebo in Adults Without HIV Status RECRUITING Phase PHASE1
NCT06724614 Efficacy and Safety of VDPHL01 in Males With AGA Status ACTIVE_NOT_RECRUITING Phase PHASE2/PHASE3
NCT06724432 Analgesic and Antioxidant Effects of Melatonin in Pediatric Surgery Status COMPLETED Phase NA
NCT06723405 Efficacy Study of EVO301 in Moderate to Severe Atopic Dermatitis Status COMPLETED Phase PHASE2
NCT06722950 Phase II Clinical Study of AC591 in Preventing Oxaliplatin-Induced Peripheral Neuropathy Status NOT_YET_RECRUITING Phase PHASE2
NCT06722729 A Late Phase II Clinical Trial of KDT-3594 in Patients With Parkinson's Disease Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT06722586 Sirolimus Monotherapy in the Treatment of Antiphospholipid Antibody Related Thrombocytopenia Status RECRUITING Phase PHASE4
NCT06722534 Celecoxib for Prevention of Progression in Peutz-Jeghers Syndrome Status RECRUITING Phase NA
NCT06722235 A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia Status RECRUITING Phase PHASE3
NCT06721156 A Study to Evaluate the Efficacy and Safety of MK-1167 in Participants With Alzheimer's Disease Dementia (MK-1167-008) Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT06721143 A Study to Investigate the Safety, Tolerability, and Preliminary Efficacy With AION-301 Administered by Intravenous Infusion Compared With Placebo Administered by Intravenous Infusion Investigational Intervention in Participants Aged 35 to 75 Years of Age With Chronic Kidney Disease (CKD) Status RECRUITING Phase PHASE1/PHASE2
NCT06721091 Safety, Tolerability, and Dose Response of VNA-318 in Healthy Males Status COMPLETED Phase PHASE1
NCT06721013 A Study of Pirtobrutinib in Participants With Immune Thrombocytopenia Status RECRUITING Phase PHASE1/PHASE2